Showing 7 of 7 recruiting trials for “nephrotic-syndrome-without-extrarenal-manifestations”
A Study to Evaluate the Safety, Tolerability and PK of SK-09
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Effects of Exogenous Ketosis on Proteinuria and Renal Function
👨⚕️ Trine Z Lyksholm, MD, University Clinic in Nephrology and Hypertenion, Godstrup Region Hospital📍 1 site📅 Started Sep 2024View details ↗
Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
👨⚕️ Anna Matyjek, Military Institute of Medicine National Research Institute📍 1 site📅 Started Jan 2023View details ↗
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingNCT01209000 ↗
Nephrotic Syndrome Study Network
RecruitingNCT01094327 ↗
Proteinuria in Pre and Post Transplant
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →